We are live on
!
Find out more
NSEDCP
NJ State Employees Deferred Compensation Plan Portfolio holdings
AUM
$906M
1-Year Est. Return
24.85%
This Fund
S&P 500
This Quarter
Est. Return
+20.46%
1 Year Est. Return
+24.85%
3 Year Est. Return
+127.22%
5 Year Est. Return
+201.43%
10 Year Est. Return
+564.84%
AUM
$648M
AUM Growth
+$91.1M
(+16%)
Cap. Flow
-$1.29M
Cap. Flow
% of AUM
-0.2%
Top 10 Holdings %
Top 10 Hldgs %
24.72%
Holding
510
New
18
Increased
1
Reduced
8
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$3.14M |
| 2 |
Concentrix
CNXC
|
+$594K |
| 3 |
UMB Financial
UMBF
|
+$257K |
| 4 |
MAGN
Magnera Corp
MAGN
|
+$247K |
| 5 |
INVX
Innovex International
INVX
|
+$227K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.17M |
| 2 |
Microsoft
MSFT
|
+$1.59M |
| 3 |
IMMU
Immunomedics Inc
IMMU
|
+$1.27M |
| 4 |
T-Mobile US
TMUS
|
+$741K |
| 5 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
+$736K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.96% |
| 2 | Healthcare | 13.05% |
| 3 | Financials | 12.76% |
| 4 | Industrials | 12.22% |
| 5 | Consumer Discretionary | 9.32% |
Similar funds
IAM
BFS
MSAM
SAM
CP
EAM
HWM
BVDMP
NJ State Employees Deferred Compensation Plan's Q4 2020 Portfolio in Review
As of Q4 2020, NJ State Employees Deferred Compensation Plan held 510 positions worth $648M, up 16% from $557M the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Trading was light in Q4 2020: portfolio turnover was 4.7%. NJ State Employees Deferred Compensation Plan opened 18 new positions and exited 6, leaving the 510-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.
- NJ State Employees Deferred Compensation Plan's largest Q4 2020 buy was RTX Corp: 47,715 shares worth $3.41M.
- NJ State Employees Deferred Compensation Plan added most to Viatris in Q4 2020, an estimated $105K increase.
- NJ State Employees Deferred Compensation Plan's biggest Q4 2020 reduction was Apple, cutting an estimated $2.17M.
- NJ State Employees Deferred Compensation Plan fully exited Immunomedics Inc in Q4 2020, selling an estimated $1.27M.
- NJ State Employees Deferred Compensation Plan's ten largest holdings make up 25% of its $648M portfolio in Q4 2020.
- NJ State Employees Deferred Compensation Plan opened 18 new positions and closed 6 in Q4 2020.
- NJ State Employees Deferred Compensation Plan's portfolio value rose 16% quarter-over-quarter to $648M.
Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q4 2020, filed 2 Feb 2021.